UK markets open in 2 hours 45 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
321.79-6.46 (-1.97%)
At close: 04:03PM EDT
321.79 0.00 (0.00%)
After hours: 04:32PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 24.73B
Enterprise value 24.34B
Trailing P/E 37.23
Forward P/E 36.50
PEG ratio (5-yr expected) 4.69
Price/sales (ttm)8.71
Price/book (mrq)10.20
Enterprise value/revenue 8.31
Enterprise value/EBITDA 26.74

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-28.41%
S&P500 52-week change 3-3.56%
52-week high 3475.35
52-week low 3275.89
50-day moving average 3313.16
200-day moving average 3369.09

Share statistics

Avg vol (3-month) 3410.78k
Avg vol (10-day) 3270.16k
Shares outstanding 574.05M
Implied shares outstanding 6N/A
Float 873.63M
% held by insiders 10.62%
% held by institutions 196.97%
Shares short (28 Jul 2022) 4912.13k
Short ratio (28 Jul 2022) 42.05
Short % of float (28 Jul 2022) 41.60%
Short % of shares outstanding (28 Jul 2022) 41.23%
Shares short (prior month 29 Jun 2022) 4906.81k

Dividends & splits

Forward annual dividend rate 40.72
Forward annual dividend yield 40.22%
Trailing annual dividend rate 30.71
Trailing annual dividend yield 30.22%
5-year average dividend yield 40.37
Payout ratio 47.92%
Dividend date 302 Aug 2022
Ex-dividend date 418 Jul 2022
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 23.41%
Operating margin (ttm)26.94%

Management effectiveness

Return on assets (ttm)15.67%
Return on equity (ttm)30.76%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)39.26
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)1.18B
EBITDA 913M
Net income avi to common (ttm)685.6M
Diluted EPS (ttm)8.97
Quarterly earnings growth (yoy)0.60%

Balance sheet

Total cash (mrq)718.5M
Total cash per share (mrq)9.7
Total debt (mrq)332.5M
Total debt/equity (mrq)13.72
Current ratio (mrq)3.13
Book value per share (mrq)32.76

Cash flow statement

Operating cash flow (ttm)675.2M
Levered free cash flow (ttm)268.31M